Search results
Chronic Lymphocytic Leukemia: Slow-Appearing Symptoms
Verywell Health via Yahoo News· 11 months agoNew therapies are transforming treatment Halfpoint Images / Getty Images Medically reviewed by...
What Is Leukemia?
Verywell Health via Yahoo News· 1 year agoLeukemia is a form of blood cancer that starts in your bone marrow, the spongy tissue inside your bones. It occurs when abnormal cells grow too fast and...
Bristol Myers cell therapy wins first-of-its-kind approval
BioPharma Dive via Yahoo Finance· 3 months agoSold as Breyanzi, the therapy is now cleared for use in certain adults with hard-to-treat forms of...
Local man to host sixth Light the Night walk
Chillicothe Gazette via Yahoo News· 8 months agoCHILLICOTHE — For the sixth time local man, Dave Reitz, will be hosting a Light the Night event in Downtown Chillicothe to raise money for the Leukemia &...
Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study
Zacks via Yahoo Finance· 2 months agoRoche Holding AG RHHBY announced that the late-stage study evaluating its marketed drug, Columvi...
LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Cancer Program
Benzinga via Yahoo Finance· 2 years agoLAVA Therapeutics N.V. (NASDAQ: LVTX) hosted a clinical update call focused on initial Phase 1/2a...
What Is Bone Marrow Cancer?
Verywell Health via Yahoo News· 1 year agoBone marrow is the tissue in the center of bones that produces blood cells. Cancers that develop in the bone marrow include leukemia, which affects the...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 4 weeks agoAs the earnings come to an end in the ongoing reporting cycle, the focus shifts to pipeline and...
US FDA expands use of Bristol Myers' cancer therapy (March 14)
Reuters via Yahoo News· 3 months agoThe U.S. Food and Drug Administration on Thursday expanded the use of Bristol Myers Squibb's cell...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi's Label Expansion
Zacks via Yahoo Finance· 3 months agoBristol Myers (BMY) obtains FDA approval for the label expansion of CAR T cell therapy, Breyanzi,...